UK ‘invention agency’ grants £50m of public money to US tech and venture capital firms – Image for illustrative purposes only (Image credits: Unsplash)
The Advanced Research and Invention Agency (ARIA), Dominic Cummings’ brainchild for backing bold scientific ventures, has directed £50 million in UK taxpayer funds toward US technology firms and venture capital initiatives. Established to champion high-risk projects capable of restoring Britain’s status as a scientific powerhouse, the agency committed these resources as part of its broader research portfolio. A joint investigation highlighted that this sum equates to more than one-eighth of ARIA’s £400 million in research and development spending over the past two years.[1]
Genesis of a High-Risk Funder
Parliament created ARIA in 2022, drawing inspiration from the US Defense Advanced Research Projects Agency (DARPA), known for breakthroughs like the internet and GPS. Dominic Cummings, Boris Johnson’s former chief adviser, advocated for the agency to support “crazy” ideas unhindered by bureaucracy. Lawmakers granted it an initial £800 million budget and exempted it from freedom of information requests to foster agility.[1]
The government’s vision positioned ARIA to drive economic growth, scientific progress, and improved quality of life through transformative research. Over time, funding commitments grew, with recent announcements boosting annual allocations toward £400 million by 2030. Program directors received up to £50 million each to pursue speculative areas like AI safety and advanced robotics. Yet the agency’s structure, which avoids taking equity or intellectual property stakes, has drawn questions about value capture.[2]
Details of the US Commitments
Transparency reports revealed ARIA spent £23 million across nine US tech firms, with an extra £6 million awarded to Normal Computing shortly after it established a UK presence. Venture capital recipients included £29.4 million to groups such as Pillar VC (£10.9 million), Renaissance Philanthropy (£13.3 million, supported by ex-Google CEO Eric Schmidt), CIC Venture Café Global Institute (£5.4 million), and Fifty Years (£7 million). These funds support activities like entrepreneur events, startup training courses, and talent scouting.[1]
Among tech grantees, Rain Neuromorphics – backed by OpenAI’s Sam Altman – received support despite reported financial woes. Other beneficiaries included MorphoAI, linked to Y Combinator, and Sangtera, tied to the US National Science Foundation. ARIA emphasized contractual terms requiring UK-based operations or reinvestments, such as Normal Computing’s claim of returning 150% of its award through local salaries and growth.[1]
- Rain Neuromorphics: AI chip developer, near-collapse concerns.
- Normal Computing: £6m, rapid UK setup.
- MorphoAI: Expanded London operations post-grant.
- Pillar VC: £10.9m for UK tech talent support.
- Renaissance Philanthropy: £13.3m, multi-country R&D focus.
Voices of Criticism Emerge
Economist Cecilia Rikap of University College London described the pattern as taxpayer money bolstering the US tech sector under the guise of moonshot innovation. She argued it expands American platforms’ control over data and knowledge co-produced with UK partners. Chi Onwurah, chair of the Commons science and technology committee, called for greater oversight, noting the ARIA Act mandates benefits to the UK economy and society.[1]
Onwurah highlighted regional disparities, with the West Midlands receiving just 0.8% of funds while overseas investments proliferate. Critics like the ETC Group labeled ARIA’s approach as importing Silicon Valley’s “move fast and break things” mindset. Questions persist on enforcing returns, given ARIA’s policy of royalties only on IP commercialized abroad, without standard equity holdings.[1]
ARIA Responds on Priorities and Protections
ARIA maintained that over 80% of its funding supports UK-based teams, with international awards designed to import expertise and capabilities. Contracts include safeguards ensuring benefits return to Britain, such as technology transfers and local economic impacts. Recipients like Fifty Years noted the grants enabled UK program delivery, funding two emerging companies, while CIC stressed taxes paid locally.[1]
The agency defended its model as essential for accessing global talent in competitive fields. MorphoAI reported shifting over half its workforce to London following the award. Officials reiterated the mission: funding the best ideas worldwide to unlock UK breakthroughs, without rigid geographic limits.[1]
Broader Questions for UK Research Policy
ARIA’s choices reflect tensions in balancing domestic priorities with global collaboration. While the agency has launched programs in AI infrastructure and climate technologies, the US focus underscores challenges in retaining innovation value at home. Stakeholders await clearer metrics on returns, especially as budgets expand amid calls for transparency reforms.[1]
As Britain invests billions in R&D to compete internationally, ARIA’s trajectory will test whether high-risk bets yield national gains or primarily fuel overseas ecosystems. Lawmakers and experts urge refined guidelines to prioritize untapped UK potential, ensuring public funds align with statutory goals. The debate highlights the complexities of fostering homegrown science in a borderless tech landscape.